Lab Testing Sample Clauses

Lab Testing. Consistent with good laboratory practices and applicable clinical and molecular laboratory laws Atossa shall perform the ForeCYTE Test at the NRLBH for the Collection Kits submitted by the Distributor ForeCYTE Customers. Distributor acknowledges that Atossa owns U.S. patents and patent applications on the ForeCYTE Test and ForeCYTE Products and that those patents prohibit others from performing laboratory services on specimens collected with the Pump and the Collection Kits. Distributor shall not cause, directly or indirectly, any Collection Kits to be provided to any laboratory other than the NRLBH.
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs
Lab Testing. Verily will be responsible for contracting with a laboratory to conduct all testing of samples collected through the Program (the “Testing Lab”). If Verily determines that an alternative approach to laboratory testing has become feasible during the course of the Program, Verily will notify State and/or the applicable Counties and the parties will collaborate in good faith to adjust the workflow and third party contracting, as appropriate, to accommodate the new approach.
Sample 1
Lab Testing. Subject always to the best interests of the patients of the Clinic and to any applicable professional or legal restrictions, ______________ shall make use of such laboratory facilities for testing and other purposes as may be specified from time to time by the Clinic.
Sample 1
Lab Testing. Company shall cooperate with Distributor for the rebottling aging test. The Distributor will be responsible for sending samples using Fedex to Company for testing. Company shall provide test reports back to Distributor.
Sample 1
Lab Testing. Vendor’s testing methodologies have all been determined by the Center for Disease Control and Prevention (“CDC”) and U.S. Food and Drug Administration (“FDA”) to be acceptable emergency use authorized tests. Vendor performs molecular COVID-19 tests and uses the “short swab” technique. Vendor will only use nasopharyngeal or nasal swabs collection techniques employed in the anterior nares. Vendor will perform all COVID-19 PCR testing for CPS at its Elmwood Park, New Jersey location. Vendor’s other laboratory locations will serve as backup laboratories if and when Elmwood Park is unable to process specimens. The specimens will be collected at the school or facility locations selected by CPS and then transported to Vendor’s laboratory locations where they will be accessioned and then tested on one of Vendor’s Emergency Use Authorization (“EUA”) FDA authorized instruments. All test specimens will be transported by Vendor to its labs in a temperature regulated environment. Vendor will continue to look at all emerging technologies and adapt testing to the needs of the patients and communities. If a new technology emerges that the Board and Vendor agrees is a more effective testing technology, Vendor will agree to utilize that technology if directed to do so by the Board. Vendor uses FDA EUA platforms for real time RT-PCR testing for COVID-19. Real time RT- PCR Testing is a nuclear-derived method for detecting the presence of specific genetic material in any pathogen. Vendor has utilized the following four platforms: 1) Roche assay: COBAS 8800 2) ThermoFisher assay: APPLIED BIOSYSTEMS 7500 FAST DX and THERMOFISHER QUANT12KFLEX 3) Hologic assay: PANTHER FUSION 4) Seegene assay: BIO-RAD CFX96 Under the Program, Vendor will comply with all applicable standards under the Clinical Laboratory Improvement Amendments of 1988 (“CLIA”) and College of American Pathologists. Vendor further operates a CLIA-certified laboratory, where it runs its PCR tests and can report results back to the individual and CPS within 48 hours of receiving the test sample. Vendor’s lab has the capacity to process a minimum of ten thousand (10,000) tests weekly for CPS. Vendor’s lab also has the capability to process larger test numbers in the event that CPS expands the Program. If Vendor cannot analyze a specimen because of improper collection or degradation in process, or is unable to obtain satisfactory test results, Vendor will notify Board and arrange for any resampling necessary. In the even...
Sample 1
Lab Testing. Soil samples recovered by the geologist during the geo-technical investigation will be taken to Ninyo & Moore’s laboratory, where testing shall be completed to address index soil characteristics for both soil classification and correlation with soil mechanical characteristics (i.e., strength and compressibility).
Sample 1
AutoNDA by SimpleDocs

Related to Lab Testing

  • ODUF Testing 6.6.1 Upon request from TWTC, AT&T shall send ODUF test files to TWTC. The Parties agree to review and discuss the ODUF file content and/or format. For testing of usage results, AT&T shall request that TWTC set up a production (live) file. The live test may consist of TWTC’s employees making test calls for the types of services TWTC requests on ODUF. These test calls are logged by TWTC, and the logs are provided to AT&T. These logs will be used to verify the files. Testing will be completed within thirty (30) days from the date on which the initial test file was sent.

  • Random Testing Notwithstanding any provisions of the Collective Agreement or any special agreements appended thereto, section 4.6 of the Canadian Model will not be applied by agreement. If applied to a worker dispatched by the Union, it will be applied or deemed to be applied unilaterally by the Employer. The Union retains the right to grieve the legality of any imposition of random testing in accordance with the Grievance Procedure set out in this Collective Agreement.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Meter Testing Company shall provide at least twenty-four (24) hours' notice to Seller prior to any test it may perform on the revenue meters or metering equipment. Seller shall have the right to have a representative present during each such test. Seller may request, and Company shall perform, if requested, tests in addition to the every fifth-year test and Seller shall pay the cost of such tests. Company may, in its sole discretion, perform tests in addition to the fifth year test and Company shall pay the cost of such tests. If any of the revenue meters or metering equipment is found to be inaccurate at any time, as determined by testing in accordance with this Section 10.2 (Meter Testing), Company shall promptly cause such equipment to be made accurate, and the period of inaccuracy, as well as an estimate for correct meter readings, shall be determined in accordance with Section 10.3 (Corrections).

  • Product Testing No later than [**] prior to a scheduled Delivery ARIAD US shall send to ARIAD SWISSCO the Delivery Documents for review. Following such review, unless within [**] of receipt of the Delivery Documents ARIAD SWISSCO gives written notice of rejection of the Product to be delivered, stating the reasons for such rejection, the Delivery shall proceed, and both Parties shall organize the same. Upon arrival at ARIAD SWISSCO nominated site it shall visually inspect the shipment of the Product to identify any damage to the external packaging. ARIAD SWISSCO may reject any shipment (or portion thereof) of the Product that is damaged by providing to ARIAD US reasonable evidence of damage within [**] after Delivery of such Product. If ARIAD SWISSCO does not so reject any shipment (or portion thereof) of the Product within [**] of Delivery of such Product, ARIAD SWISSCO shall be deemed to have accepted such shipment of the Product; provided, however, that in the case of the Product having any Latent Defect, ARIAD SWISSCO shall notify ARIAD US promptly once it becomes aware that a Product contains a Latent Defect and subsequently may reject such Product by giving written notice to ARIAD US of ARIAD SWISSCO’s rejection of such Product and shipping a representative sample of such Product or other evidence of Non-Conformance to ARIAD US within [**] after becoming aware of such Latent Defect, which notice shall include a description of the Latent Defect.

  • Stability Testing Patheon may be requested to conduct stability testing on the Products in accordance with the protocols set out in the Specifications for the separate fees and during the time periods set out in Schedule C to a Product Agreement. Patheon will not make any changes to these testing protocols without prior written approval from Client. If a confirmed stability test failure occurs, Patheon will notify Client within one Business Day, after which Patheon and Client will jointly determine the proceedings and methods to be undertaken to investigate the cause of the failure, including which party will bear the cost of the investigation. Patheon will not be liable for these costs unless it has failed to perform the Manufacturing Services in accordance with the Specifications, cGMPs, and Applicable Laws. Patheon will give Client ail stability test data and results at Client’s request.

  • Performance Testing 7.2.1 The Design-Builder shall direct and supervise the tests and, if necessary, the retests of the Plant using Design-Builder’s supervisory personnel and the Air Emissions Tester shall conduct the air emissions test, in each case, in accordance with the testing procedures set forth in Exhibit A (the “Performance Tests”), to demonstrate, at a minimum, compliance with the Performance Guarantee Criteria. Owner is responsible for obtaining Air Emissions Tester and for ensuring Air Emissions Tester’s timely performance. Design-Builder shall cooperate with the Air Emissions Tester to facilitate performance of all air emissions tests. Design-Builder shall not be held responsible for the actions of Owner’s employees and third parties involved in the Performance Testing, including but not limited to Air Emissions Tester. 7.2.2 No later than thirty (30) Days prior to the earlier of the Scheduled Substantial Completion Date or Substantial Completion, Design-Builder shall provide to Owner for review a detailed testing plan for the Performance Tests (other than for air emissions). Owner and Design-Builder shall agree upon a testing plan that shall be consistent with the Performance Test Protocol contained in Exhibit A hereto. After such agreement has been reached, Design-Builder shall notify the Owner five (5) business days prior to the date Design-Builder intends to commence the Performance Tests and shall notify the Owner upon commencement of the Performance Tests. Owner and Independent Engineer each have the right to witness all testing, including the Performance Tests and any equipment testing, whether at the Site or at the Subcontractor’s or equipment supplier’s premises during the course of this Agreement. Notwithstanding the foregoing sentence, Owner shall bear the costs of providing a witness to any such testing and all such witnesses shall comply at all times with Design-Builder’s, Subcontractor’s or equipment supplier’s safety and security procedures and other reasonable requirements, and otherwise conduct themselves in a manner that does not interfere with Design-Builder’s, Subcontractor’s or equipment supplier’s activities or operations. 7.2.3 Design-Builder shall provide to Owner a Performance Test report (excluding results from air emissions testing), including all applicable test data, calculations and certificates indicating the results of the Performance Tests and, within five (5) business days of Owner’s receipt of such results, Owner, Independent Engineer and Design-Builder will jointly inspect such Work and review the results of the Performance Tests to verify that the Performance Guarantee Criteria have been met. If Owner or Independent Engineer reasonably determines that the Performance Guarantee Criteria have not been met, Owner shall notify Design-Builder the reasons why Owner determined that the Performance Guarantee Criteria have not been met and Design-Builder shall promptly take such action or perform such additional work as will achieve the Performance Guarantee Criteria and shall issue to the Owner another notice in accordance with Section 7.2.2; provided however that if the notice relates to a retest, the notice may be provided no less than two (2) business days prior to the Performance Tests. Such procedure shall be repeated as necessary until Owner and Independent Engineer verifies that the Performance Guarantee Criteria have been met. 7.2.4 If Owner, for whatever reason, prevents Design-Builder from demonstrating the Performance Guarantee Criteria within thirty (30) Days of Design-Builder’s notice that the Plant is ready for Performance Testing, then Design-Builder shall be excused from demonstrating compliance with the Performance Guarantee Criteria during such period of time that Design-Builder is prevented from demonstrating compliance with the Performance Guarantee Criteria; provided however that Design-Builder will be deemed to have fulfilled all of its obligations to demonstrate that the Plant meets the Performance Guarantee Criteria should such period of time during which Design-Builder is prevented from demonstrating the Performance Criteria exceed thirty (30) Days or extend beyond the Final Completion Date.

  • Substance Abuse Testing The Parties agree that it is in the best interest of all concerned to promote a safe working environment. The Union has no objection to pre-employment substance abuse testing when required by the Employer and further, the Union has no objection to voluntary substance abuse testing to qualify for employment on projects when required by a project owner. The cost and scheduling of such testing shall be paid for and arranged by the Employer. The Union agrees to reimburse the Employer for any failed pre-access Alcohol and Drug test costs.

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!